Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Private Portals: Where’s the Payback?

Private Portals: Where’s the Payback?

Sep 01, 2000
Premium

Veteran computational biologist NAT GOODMAN tries out the new online bioinformatics businesses.

This summer, while the world welcomed the human genome sequence, I paid visits to some of the new commercial bioinformatics websites that are meant to help you analyze it. I came away disappointed by a field of products stuck in pre-genomic thinking.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Another Study for AstraZeneca

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna to Seek EUA

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

To Spot it Earlier

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

PLOS Papers on Glioblastoma in Lebanon, Syndromic Gene PheWAS, Newborn Cytokine GWAS

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.